Silexion Therapeutics (SLXN) Depreciation & Amortization (CF) (2023 - 2026)
Silexion Therapeutics (SLXN) reported Depreciation & Amortization (CF) of $3,000 for Q2 2026, unchanged from $3,000 a year earlier and up 50.0% from the prior quarter.
Powered by 
Analysis
Silexion Therapeutics (SLXN) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Silexion Therapeutics' Depreciation & Amortization (CF) came in at $12,000, down 29.4% year-over-year; for FY2025, it came in at $14,000, down 44.0% from FY2024.
- By year, Depreciation & Amortization (CF) came in at $25,000 in FY2024 (-44.4%) and $45,000 in FY2023.
- Five-year quarterly Depreciation & Amortization (CF) spans a low of -$12,000 in Q4 2024 and a high of $22,000 in Q3 2024.
- Year over year, Depreciation & Amortization (CF) gained in 1 of the last six quarters, with an average decline of 19.8%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $2,000 (Q1 2026), $3,000 (Q4 2025) and $4,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 1.96 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 1.62 Bn |
| 10 | Silexion Therapeutics | 192,458.84 | -19.68 Mn | - | 3,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | -12,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 14,000.00 |
API Access
Silexion Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SLXN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "SLXN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SLXN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();